Latest MBOT reports update at 2024-03-27: 20232022
Microbot Medical  logo
Microbot Medical MBOT
$ 0.98 -1.87%

Microbot Medical Financial Ratios 2011-2024 | MBOT

Annual Financial Ratios Microbot Medical

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.1 -1.3 -3.5 -6621.7 -5.3 -3.3 -4.5 -7.2 -0.9 -2.1 -2.4 -1.7 -0.7

P/S

- - - - - - - - 286.9 69.4 52.3 35.4 12.1

EPS

-1.1 -1.8 -1.6 -1.3 -1.7 -2.4 -2.8 0.4 0.0 -0.2 -0.6 -1.0 -1.5

EV (Enterprise Value)

13.1 M 16.6 M 28.1 M 41.1 M 15 M 23.7 M 24.6 M 68.3 M 54.6 M 96 M 89.2 M 56.1 M 15.9 M

EBITDA per Share

-0.96 -1.82 -1.59 -0.00128 -1.69 -2.48 -2.41 -10.1 -595 -778 -1.03 K -1.19 K -2.96 K

EV/EBITDA

-2.2 -6669.0 -1.3 -2.6 -4.5 -6.9 -0.9 -2.0 -1.7 -1.9 -0.1

PEG

-0.0 -0.0 -0.0 -66.27 -0.18 -0.31 -0.08 -0.07 -0.03 -0.16 -0.06 -0.05 -0.03

P/B

2.6 2.3 2.7 2497.7 1.2 18.3 3.4 40.9 -100.3 12.0 4.2 3.5 1.4

P/CF

-1.4 -1.5 -4.2 -8268.3 -5.7 -4.4 -7.0 -85.5 -1.1 -2.5 -2.2 -2.4 -0.7

ROE %

-238.61 -180.66 -78.67 -37.72 -22.98 -547.66 -76.16 -569.75 10895.85 -557.70 -176.81 -203.73 -198.87

ROA %

-128.98 -138.07 -67.47 -34.89 -19.52 -118.88 -68.87 -286.91 -171.61 -100.97 -63.62 -94.43 -84.62

ROCE %

-218.95 -182.21 -78.97 -36.77 -22.41 -544.66 -50.20 -372.73 -318.97 -147.69 -88.03 -88.50 -138.78

Current Ratio

2.2 4.2 7.0 18.8 7.4 1.2 20.7 4.2 1.5 2.3 3.5 4.7 3.1

DSO

- - - - - - - - 166.8 149.8 180.5 83.0 80.1

DIO

- - - - - - - - - - - - -

DPO

- - 52.9 - - - - - - - 304.2 300.8 1812.2

Operating Cycle

- - - - - - - - - - 180.5 83.0 80.1

Cash Conversion Cycle

- - -52.9 - - - - - - - -123.7 -217.8 -1732.0

All numbers in USD currency

Quarterly Financial Ratios Microbot Medical

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.21 -0.25 -0.36 - -0.49 -0.49 -0.45 - -0.36 -0.35 -0.34 - -0.35 -0.26 -0.31 - -0.44 -0.36 -0.48 - -0.6 -0.66 -0.5 - -0.45 -0.09 0.04 - -0.08 -0.01 -0.01 -0.08 -0.005 -1.07 -1.62 -0.15 -0.04 -0.21 -0.14 -0.13 -0.17 -0.15 -0.17 -0.07 -0.54 0.03 -0.45 - -0.31 -0.29 -0.42

EBITDA per Share

- - -0.36 - -0.48 -0.5 -0.44 - -0.35 -0.34 -0.33 - -0.33 -0.26 -0.3 - -0.41 -0.35 -0.47 - -0.58 -0.65 -0.54 - -0.52 -0.04 -0.05 - -0.05 0.01 0.06 - 0.11 -1.1 -1.51 - -0.08 -0.13 -0.12 - -0.14 -0.14 -0.16 - -0.14 -0.19 -0.22 - -0.37 -0.47 -0.32

ROE %

-178.93 -208.36 -225.34 -131.26 -145.55 -97.17 -68.52 -37.47 -47.64 -43.51 -38.66 -26.87 -32.81 -28.59 -25.84 -17.05 -149.23 -275.47 -412.98 -386.02 -462.18 -406.16 -339.92 -165.45 -735.20 -1228.79 -1722.37 -1709.26 -1698.08 -1117.16 1984.45 5340.88 5293.92 5235.78 2497.56 -383.13 -2241.38 -2242.51 -2075.39 -1988.50 -149.97 -218.70 -173.50 -203.73 -224.42 -148.01 -191.59 -131.62 -40.41 -37.62 -53.59

ROA %

-141.30 -160.59 -172.90 -103.44 -116.41 -82.57 -60.73 -34.33 -43.74 -40.18 -35.75 -24.86 -29.90 -25.54 -22.64 -14.48 -43.35 -67.17 -94.12 -84.30 -153.17 -193.17 -230.93 -149.59 -436.50 -654.54 -872.58 -860.72 -860.89 -574.16 -327.14 -84.12 -92.62 -100.95 -98.43 -69.36 -86.12 -94.92 -71.68 -63.62 -56.01 -92.85 -75.97 -94.43 -102.49 -65.54 -84.31 -56.01 -17.20 -16.01 -22.80

ROCE %

-62.79 -125.57 -167.30 -131.84 -146.12 -97.61 -68.20 -37.30 -47.24 -42.89 -38.33 -26.58 -32.26 -28.01 -25.15 -16.65 -148.46 -274.58 -411.94 -387.97 -400.36 -280.95 -151.36 -37.43 -75.47 -101.10 -81.48 -14.27 -5.38 41.53 2809.05 5464.43 5355.76 5238.21 2328.15 -360.79 -405.30 -341.15 -247.17 -127.96 -164.26 -156.06 -152.71 -112.64 -170.11 -191.27 -219.12 -193.59 -57.46 -66.11 -70.02

Current Ratio

5.8 7.7 4.6 4.2 4.0 5.3 6.6 7.0 10.8 12.5 13.1 13.3 13.3 13.3 13.3 6.7 6.7 6.7 6.7 1.3 1.3 1.3 1.3 19.8 19.8 19.8 19.8 2.9 2.9 2.9 2.9 1.3 1.0 1.0 1.0 0.0 1.2 1.2 1.2 1.6 1.6 1.6 1.6 1.9 1.9 1.9 1.9 1.7 1.7 1.7 1.7

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 4.1 6.6 30.1 383.8 16.5 176.6 632.7 519.0 220.7 30.6 35.2 35.1 47.6 38.1 40.4 11.7 - 22.2 21.2 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 4.1 6.6 30.1 383.8 16.5 176.6 632.7 519.0 220.7 30.6 35.2 35.1 47.6 38.1 40.4 11.7 - 22.2 21.2 -

Cash Conversion Cycle

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 4.1 6.6 30.1 383.8 16.5 176.6 632.7 519.0 220.7 30.6 35.2 35.1 47.6 38.1 40.4 11.7 - 22.2 21.2 -

All numbers in USD currency